Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    April 2022
  1. RAJAMAKI A, Hujo M, Sund R, Prusila REI, et al
    Mortality among patients with low-grade follicular lymphoma: A binational retrospective analysis.
    Cancer. 2022 Apr 13. doi: 10.1002/cncr.34221.
    PubMed     Abstract available


  2. GANGARAJU R, Davis ES, Bhatia S, Kenzik KM, et al
    Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
    Cancer. 2022 Apr 1. doi: 10.1002/cncr.34210.
    PubMed     Abstract available


  3. HUTCHESON KA, Barbon CEA, Alvarez CP, Warneke CL, et al
    Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2.
    Cancer. 2022;128:1458-1466.
    PubMed     Abstract available


    February 2022
  4. CHOW EJ, Aplenc R, Vrooman LM, Doody DR, et al
    Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.
    Cancer. 2022;128:788-796.
    PubMed     Abstract available


  5. TORKA P, Akhtar OS, Reddy NM, Baysal BE, et al
    Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma, results of a phase 2 study.
    Cancer. 2022 Feb 14. doi: 10.1002/cncr.34106.
    PubMed     Abstract available


    January 2022

  6. Erratum to "Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation".
    Cancer. 2022 Jan 27. doi: 10.1002/cncr.33973.
    PubMed    


  7. NOONE AM, Pfeiffer RM, Schaubel DE, Dorgan JF, et al
    Life-years lost due to cancer among solid organ transplant recipients in the United States, 1987 to 2014.
    Cancer. 2022;128:150-159.
    PubMed     Abstract available


    December 2021
  8. BACHIASHVILI K, Francisco L, Chen Y, Bosworth A, et al
    Peripheral blood parameter abnormalities precede therapy-related myeloid neoplasms after autologous transplantation for lymphoma.
    Cancer. 2021 Dec 28. doi: 10.1002/cncr.34072.
    PubMed     Abstract available


  9. WONG SM, Ajjamada L, Weiss AC, Prakash I, et al
    Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Cancer. 2021 Dec 17. doi: 10.1002/cncr.34065.
    PubMed     Abstract available


  10. UNGER JM, Beauchemin M, Hershman DL
    Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
    Cancer. 2021;127:4574-4584.
    PubMed     Abstract available


    November 2021
  11. WADHWA A, Adams KM, Dai C, Richman JS, et al
    Association between body composition and chemotherapy-related toxicity in children with lymphoma and rhabdomyosarcoma.
    Cancer. 2021 Nov 30. doi: 10.1002/cncr.34043.
    PubMed     Abstract available


  12. LEUPIN N, Zinzani PL, Morschhauser F, Dalle S, et al
    Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.
    Cancer. 2021 Nov 2. doi: 10.1002/cncr.34005.
    PubMed     Abstract available


    October 2021
  13. NERICH V, Guyeux C, Henry-Amar M, Couturier R, et al
    Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33938.
    PubMed     Abstract available


    September 2021
  14. KAHN JM, Maguire FB, Li Q, Abrahao R, et al
    Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population-based study.
    Cancer. 2021 Sep 8. doi: 10.1002/cncr.33868.
    PubMed     Abstract available


    August 2021
  15. KLISOVIC RB, Leung WH, Brugger W, Dirnberger-Hertweck M, et al
    A phase 2a, single-arm, open-label study of tafasitamab, a humanized, Fc-modified, anti-CD19 antibody, in patients with relapsed/refractory B-precursor cell acute lymphoblastic leukemia.
    Cancer. 2021 Aug 3. doi: 10.1002/cncr.33796.
    PubMed     Abstract available


    July 2021
  16. HU B, Boselli D, Pye LM, Chen T, et al
    Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33779.
    PubMed     Abstract available


  17. JUWEID ME, Mueller M, Alhouri A, A-Risheq MZ, et al
    Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
    Cancer. 2021 Jul 19. doi: 10.1002/cncr.33772.
    PubMed     Abstract available


    June 2021
  18. EL-GALALY TC, Ovlisen AK, Cheah CY
    Routine imaging for disease surveillance in follicular lymphoma-To comfort the patients or their doctors?
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33659.
    PubMed    


  19. GOLDMAN ML, Mao JJ, Strouse CS, Chen W, et al
    Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33660.
    PubMed     Abstract available


    November 2020
  20. TOPP MS, Gokbuget N, Zugmaier G, Stein AS, et al
    Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
    Cancer. 2020 Nov 3. doi: 10.1002/cncr.33298.
    PubMed     Abstract available


    October 2020
  21. BORTHAKUR G, Martinelli G, Raffoux E, Chevallier P, et al
    Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphoma.
    Cancer. 2020 Oct 27. doi: 10.1002/cncr.33188.
    PubMed     Abstract available


    August 2020
  22. FLORINDEZ JA, Alderuccio JP, Reis IM, Lossos IS, et al
    Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016).
    Cancer. 2020 Aug 7. doi: 10.1002/cncr.33117.
    PubMed     Abstract available


    June 2020
  23. KARSCHNIA P, Batchelor TT, Jordan JT, Shaw B, et al
    Primary dural lymphomas: Clinical presentation, management, and outcome.
    Cancer. 2020;126:2811-2820.
    PubMed     Abstract available


  24. BLESSING AM, Santiago-O'Farrill JM, Mao W, Pang L, et al
    Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32985.
    PubMed     Abstract available


    May 2020
  25. LEE MJ, Koff JL, Switchenko JM, Jhaney CI, et al
    Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-Cell lymphoma.
    Cancer. 2020 May 29. doi: 10.1002/cncr.32866.
    PubMed     Abstract available


    February 2020
  26. DE FINE LICHT S, Maraldo MV, Specht L, Nielsen TT, et al
    Risk factors for cardiovascular disease in 5-year survivors of adolescent and young adult cancer: A Danish population-based cohort study.
    Cancer. 2020;126:659-669.
    PubMed     Abstract available


    August 2019
  27. EPPERLA N, Hamadani M, Reljic T, Kharfan-Dabaja MA, et al
    Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysis.
    Cancer. 2019 Aug 23. doi: 10.1002/cncr.32464.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: